( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
Health officials in Kansas have reported a tuberculosis outbreak in the northeastern part of the state, with 67 active cases since 2024, marking one of the largest outbreaks in recorded history of the ...